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INTRODUCTION
Gastrointestinal stromal tumors (GISTs) are the most com-
mon mesenchymal tumors of the gastrointestinal (GI) tract
and may arise anywhere in the tubular GI tract from the eso-
phagus to the rectum. In terms of a more detailed distribu-
tion, 50-60% of the lesions arise in the stomach, 20-30% in
the small bowel, 10% in the large bowel and 5% in the esoph-
agus (1). In addition, it has been reported in recent years that
identical lesions also occur in the mesentery, omentum and
retroperitoneum (2). The demonstration of KIT expression
in these lesions has helped to validate their existence, partic-
ularly in exceptional sites such as the gallbladder (3, 4) or uri-
nary bladder (5). Recent studies found that GISTs are tumors
originating from the interstitial cells of Cajal (ICCs) or prim-
itive stem cells related to ICCs (6, 7). The morphologic appear-
ance of stromal tumors in the gallbladder is identical to that
of stromal tumors in the gastrointestinal tract, and ICCs are
normally distributed in the gallbladder wall (8).
The prognosis of GISTs is difficult to predict due to various
clinical patterns and morphologic characteristics and is poor
when malignant changes are present or when metastasis occurs
to the liver or peritoneal cavity in the early stage (9). Although
GISTs of the gallbladder are extremely rare, we encountered
a case of malignant GIST of the gallbladder that showed no
mutation of c-kit proto-oncogene but had CD117 antigen ex-
pression. Thus, we report this case with the literature review.
CASE REPORT
A 72-yr-old woman visited St. Paul’s Hospital of the Catho-
lic University of Korea due to symptoms of fever, chills, and
intermittent abdominal pain in the right upper quadrant that
was present for 10 days and which worsened severe on the day
of the visit. Ultrasound examination revealed a significantly
dilated gallbladder and wall thickening. Several high echo-
genic foci with low echoic debris were present in the depen-
dent portion of the gallbladder (Fig. 1). Accordingly, emer-
gency cholecystectomy was performed under the diagnosis
of gallbladder empyema.
Grossly, the gallbladder was dilated and measured 11 cm
in length and 5 cm in width. A necrotic serosal surface that
was purplish brown in color was observed. Upon opening, the
gallbladder wall was thickened and yellowish necrotic tissue
was present. A 6 cm long, 3 cm wide mass covered the entire
wall of the gallbladder neck and body. Hemorrhage and necro-
sis were present in the remainder of the mucosal layer. 
Microscopically, tumor cells were present in the entire layer
of the gallbladder, and the mucosal layer was flattened due
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Malignant Gastrointestinal Stromal Tumor of the Gallbladder
Gastrointestinal stromal tumors (GISTs) of the gallbladder are representative of an
extremely rare group of tumors. We have encountered a patient with a malignant
GIST of the gallbladder and presented it with a review of some articles. A 72-yr-old
woman initially presented with right upper quadrant abdominal pain, fever and chills.
Emergency cholecystectomy was performed under the impression of gallbladder
empyema. Liver metastasis was found at 7 months postoperatively and the patient
expired 9 months after the surgery. At the time of cholecystectomy, the gallbladder show-
ed a necrotic serosal surface with an irregular thickened wall. A mass, 6 cm in length
and 3 cm in width, encircled the whole wall of the neck and upper body of the gall-
bladder. Microscopic findings revealed frequent mitotic figures (more than 20/50
HPF) and tumor necrosis. Hyperchromatic, pleomorphic and spindle shaped neo-
plastic cells that were arranged in a pattern of short fascicles infiltrated the entire
layer of the gallbladder. The tumor cells were immunoreactive for CD117 antigen
(c-kit protein) and vimentin. They were negative for desmin, smooth muscle actin
and S-100 protein. Mutations of the c-kit proto-oncogene were not found in this case.
These findings were sufficient to provide enough clinical, histopathological and im-
munohistochemical evidence in diagnosing our case as a malignant GIST.
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to tumor cells infiltration (Fig. 2A). Most of the tumor cells
that were of spindle shape nature with some showing a round
to oval appearance arranged in a short fascicle pattern (Fig.
2B). Hyperchromatic nuclei and severe pleomorphism were
present in these cells. There was increased mitotic activity
with mitotic counts being higher than 20/50 HPF (Fig. 2C),
and partially tumor necrosis was also observed. Immunohis-
tochemically, these tumor cells were stained diffusely with
moderate intensity for CD117 (dilution 1:50, sc-168, Santa
Cruz Biotechnology, Santa Cruz, CA, U.S.A.) in the cytoplasm
(Fig. 2D) and they were positive for vimentin (dilution 1:25,
V9, Signet Laboratories Inc., Dedham, MA, U.S.A.). How-
ever, they were negative for CD34 (dilution 1:50, N1632,
DAKO, Carpinteria, CA, U.S.A.), desmin (dilution 1:40, ZC-
18, ZYMED, San Francisco, CA, U.S.A.), smooth muscle actin
(dilution 1:100, 1A4, NeoMarkers, Fremont, CA, U.S.A.) and
S-100 protein (dilution 1:50, 4C4.9, NeoMarkers).
In order to determine the presence of c-kit gene mutation,
sample sections were deparaffinized and DNA was extracted
using the QIAamp DNA Mini Kit (QIAGEN Inc., Valencia,
CA, U.S.A.) according to the proteinase K digestion methods.
Polymerase chain reaction (PCR) was performed using the
primers for 4 regions of the c-kit gene, i.e., exons 9, 11, 13,
and 17. After the QIAquick PCR purification method (QIA-
GEN Inc.), the DNA sequence was analyzed using ABI 3700
sequencer (Applied Biosystems, Foster City, CA, U.S.A.) with
the PCR products. DNA sequencing performed to determine
the presence of the c-kit gene mutation revealed no mutation
in exons 9, 11, 13, and 17.
Liver metastasis was found in abdominal CT (Fig. 3) at 7
months postoperatively and the patient expired 9 months
after the surgical treatment.
DISCUSSION
Malignant stromal tumors of the gallbladder are extremely
rare. Although some cases of leiomyosarcoma, botryoid rhab-
domyosarcoma, angiosarcoma, and Kaposi sarcoma have been
occasionally described (10), only two benign and malignant
stromal tumors of the gallbladder with ICCs phenotype have
been reported (3, 4).
The gallbladder tumor in our case was a high risk GIST
as classified according to the risk of aggressive behavior of
GIST proposed by Fletcher et al. in the NIH consensus sym-
posium of GIST in 2001 (11). It has been expressed that the
classification of GISTs into benign and malignant categories
should be replaced by one that categorizes it into low-risk and
high-risk tumors depending on their estimated potential for
recurrence and metastasis (12). This proposal was made be-
cause lesions that are very small (less than 2 cm) and possess
very low mitotic rates (less than 5/50 HPF) occasionally meta-
stasize. With prolonged follow-up, it appears that almost all
GISTs presenting with clinical symptoms or signs which lead
to treatment have the potential to behave in a malignant fash-
ion (11). The tumor in this report was 6 cm in length and 3
cm in width and had mitotic counts of more than 20 mitoses/
50 HPF. It consisted of spindle cells most of which had hyper-
chromatic nuclei, along with significant pleomorphism and
tumor necrosis. Actin, desmin and S-100 protein expression
were absent but CD117 and vimentin expression were present.
CD117 antibody is used to detect the KIT receptor protein
and stain ICCs. 
GISTs have been proposed to originate from ICCs because
of the expression of KIT protein (7). KIT protein is also known
to be expressed in several cell types, such as hematopoietic
stem cells, mast cells, melanocytic cells, and germ cells and
is considered to play an important role in the development
and maintenance of these cellular elements (6). ICCs can easily
be identified by immunohistochemical staining since they
only express CD117, CD34 and vimentin in the gut (7). ICCs
are pacemaker cells forming the nerve network that controls
peristaltic movements of the GI tract and are located in the
myenteric plexus and dispersed between the smooth muscle
cells. It has been reported that the expression of activated KIT
protein plays a crucial role in the differentiation and prolif-
eration of ICCs (13). 
KIT protein is a 145 kDa transmembrane receptor for a
growth factor termed stem cell factor and it has an internal
tyrosine kinase component (3, 14). The extracellular portion
of KIT receptor binds to a ligand known as stem cell factor,
and the intracellular portion contains the actual kinase enzy-
matic domain (15). KIT activation normally occurs when two
adjacent receptors are brought together through binding to
Fig. 1. Preoperative ultrasound reveals a significantly dilated gall-
bladder with wall thickening. Several high echogenic foci with low
echoic debris (arrow) are present in the dependent portion of the
gallbladder.Gastrointestinal Stromal Tumor of the Gallbladder 765
ligand dimers (15). However, the oncogenic activation of KIT
protein, which is evoked by the oncogenic mutation of the c-kit
gene itself, does not depend on binding of the KIT ligand,
but instead plays a pivotal event in GIST tumorigenesis by
inducing the phosphorylation of other proteins during the cell-
signaling cascades (16). Therefore KIT expression might be
one of the earliest transforming events in GISTs (17). 
Many parameters such as tumor size, mitotic rate, mucosal
invasion, tumor necrosis, high cellularity, anatomic site, and
age have been proposed in predicting the prognosis of GISTs.
However, the morphologic features that have gained greatest
acceptance as being positive predictors of outcome are tumor
size and mitotic rate (11, 12). According to recent reports,
c-kit mutation results in an increase in both tumor size and
mitotic rate leading to a clinically unfavorable prognosis (1).
Lasota et al. (2) and Taniguchi et al. (18) suggested that muta-
tion-positive GISTs showed a higher recurrence rate and death
rate than mutation-negative GISTs and that the c-kit muta-
tion was a strong candidate marker for predicting prognosis.
On the contrary, Sakurai et al. (19) stated that the relation-
Fig. 2. (A) The wall of gallbladder is replaced by hypercellular spindle cells and the mucosal layer epithelium has been flattened by tumor
infiltration (H&E, ×40). (B) Spindle cells are interspersed with fascicle patterns (H&E, ×100). (C) Higher magnification of spindle cells shows
hyperchromasia and prominent nucleoli of nuclei, and mitoses are frequently noted (H&E, ×400). (D) Tumor cells are stained diffusely and
show moderate intensity for CD117 in the cytoplasm (Immunostain ×400).
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ship between c-kit mutation and a poor prognosis of GISTs
could not be confirmed. Similarly, although Wardelmann et al.
(20) reported that there was correlation between the c-kit mu-
tation and increased mitoses, but there was no statistical sig-
nificance of the mutation as a prognostic factor. Even though
identification of the specific c-kit mutation might be impor-
tant in predicting clinical outcome and response to the KIT-
specific therapy (14), data on the prognostic value of c-kit mu-
tations are currently somewhat contradictory (1, 2, 18, 19) and
their therapeutic significance still remains under investigation.
C-kit activating mutation was originally reported to be
located in the juxtamembrane (exon 11) domain of the gene
(17). However, subsequent studies revealed that mutation was
in the extracellular (exon 9) and intracellular tyrosine kinase
(exon 13 and 17) domains (16). In the case of GISTs, muta-
tion usually occurs at exon 11, but when it does not occur
at exon 11, rare mutations occur at exon 9 and exon 13 (14,
16). The frequency of c-kit mutation varies widely from 15%
to 71% (18), at an average between 50-60% (2, 18, 19). How-
ever, we found no mutation in our case.
Diagnosis of the GIST of the gallbladder is not surprising
because the gallbladder is a part of the tubular GI tract, hav-
ing a common embryologic derivation. It has recently been
shown that neoplasms phenotypically identical to gastroin-
testinal tumors occur as primary tumors in extragastrointesti-
nal locations, principally in the omentum and mesentery (21).
Our case of malignant GIST of the gallbladder, which express
KIT protein while lacks the c-kit mutation, is histopatholog-
ically high risk as well as clinically malignant in nature due
to the presence of liver metastases.
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